1. Home
  2. CMPX vs HOV Comparison

CMPX vs HOV Comparison

Compare CMPX & HOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.26

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$133.99

Market Cap

877.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPX
HOV
Founded
2014
1959
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
752.4M
877.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CMPX
HOV
Price
$5.26
$133.99
Analyst Decision
Strong Buy
Hold
Analyst Count
10
1
Target Price
$13.44
$120.00
AVG Volume (30 Days)
2.2M
109.3K
Earning Date
11-05-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
20.64
Revenue
N/A
$3,140,315,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.78
P/E Ratio
N/A
$6.27
Revenue Growth
N/A
7.83
52 Week Low
$1.33
$81.15
52 Week High
$5.86
$202.00

Technical Indicators

Market Signals
Indicator
CMPX
HOV
Relative Strength Index (RSI) 63.05 61.03
Support Level $5.13 $126.50
Resistance Level $5.86 $133.22
Average True Range (ATR) 0.32 6.48
MACD 0.03 2.12
Stochastic Oscillator 52.82 94.39

Price Performance

Historical Comparison
CMPX
HOV

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.

Share on Social Networks: